Trial to Test (Z)-endoxifen, Verzenio in ER+, HER2- Breast Cancer
A clinical trial will evaluate (Z)-endoxifen plus Verzenio (abemaciclib) for the treatment of women with estrogen receptor (ER)-positive, HER2-negative breast cancer, according to a press release from Atossa Therapeutics and Quantum Leap Healthcare …